dc.contributor.authors |
Eskiler, GG; Cecener, G; Dikmen, G; Egeli, U; Tunca, B; |
|
dc.date.accessioned |
2020-02-27T07:21:33Z |
|
dc.date.available |
2020-02-27T07:21:33Z |
|
dc.date.issued |
2018 |
|
dc.identifier.citation |
Eskiler, GG; Cecener, G; Dikmen, G; Egeli, U; Tunca, B; (2018). Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 120, 88-73 |
|
dc.identifier.issn |
0928-0987 |
|
dc.identifier.uri |
https://doi.org/10.1016/j.ejps.2018.04.040 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/65563 |
|
dc.description.abstract |
The objective of the present study was to investigate the effect of tamoxifen (Tam) loaded solid lipid nano-particles (SLNs) on MCF7 Tam-resistant breast cancer cells (MCF7-TamR). Tam-SLNs were produced by the hot homogenization method. The characterization studies of Tam-SLNs demonstrated good physical stability with small particle size. The in vitro cytotoxicity results showed that Tam-SLNs enhanced the efficacy of Tam and reversed the acquired Tam resistance by inducing apoptosis, altering the expression levels of specific miRNA and the related apoptosis-associated target-genes in both MCF7 and MCF7-TamR cells without damaging the MCF10A control cells (p < 0.05). In conclusion, we demonstrated a molecular mechanism of the induction of apoptosis by Tam-SLNs in MCF7 and MCF7-TamR cells, and thus, we demonstrated that Tam-SLNs were more effective than Tam. The present study suggests that the use SLNs may be a potential therapeutic strategy to overcome Tam-resistance in breast cancer for clinical use. |
|
dc.language |
English |
|
dc.publisher |
ELSEVIER SCIENCE BV |
|
dc.subject |
Pharmacology & Pharmacy |
|
dc.title |
Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer |
|
dc.type |
Article |
|
dc.identifier.volume |
120 |
|
dc.identifier.startpage |
73 |
|
dc.identifier.endpage |
88 |
|
dc.contributor.department |
Sakarya Üniversitesi/Tıp Fakültesi/Temel Tıp Bilimleri Bölümü |
|
dc.contributor.saüauthor |
Güney Eskiler, Gamze |
|
dc.relation.journal |
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES |
|
dc.identifier.wos |
WOS:000433325400008 |
|
dc.identifier.doi |
10.1016/j.ejps.2018.04.040 |
|
dc.identifier.eissn |
1879-0720 |
|
dc.contributor.author |
Güney Eskiler, Gamze |
|